zm 336372 has been researched along with Argentaffinoma in 2 studies
N-(5-(3-dimethylaminobenzamido)-2-methylphenyl)-4-hydroxybenzamide: an inhibitor of c-Raf; activates Raf-1; structure in first source
| Excerpt | Relevance | Reference |
|---|---|---|
| "In this study, we investigated a novel treatment for carcinoid tumor cell growth based on pharmacologic Raf-1 activation using the compound ZM336372." | 1.33 | ZM336372, a Raf-1 activator, suppresses growth and neuroendocrine hormone levels in carcinoid tumor cells. ( Chen, H; Holen, K; Kunnimalaiyaan, M; Van Gompel, JJ, 2005) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 2 (100.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Van Gompel, JJ | 1 |
| Kunnimalaiyaan, M | 2 |
| Holen, K | 1 |
| Chen, H | 2 |
| Ndiaye, M | 1 |
2 other studies available for zm 336372 and Argentaffinoma
| Article | Year |
|---|---|
ZM336372, a Raf-1 activator, suppresses growth and neuroendocrine hormone levels in carcinoid tumor cells.
Topics: Benzamides; Carcinoid Tumor; Cell Cycle; Cell Line, Tumor; Cell Proliferation; Chromogranin A; Chrom | 2005 |
Neuroendocrine tumor cell growth inhibition by ZM336372 through alterations in multiple signaling pathways.
Topics: Benzamides; Carcinoid Tumor; Carcinoma, Neuroendocrine; Cell Division; Cell Line, Tumor; Extracellul | 2007 |